Bismuth with dual therapy for H. pylori infection treatment
Part of Digestive system clinical trials.
This trial tests whether adding bismuth (a mineral compound) to standard two-drug therapy helps cure H. pylori, a common stomach bacteria that can cause ulcers and inflammation. The goal is to see if this combination works better than dual therapy alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have H. pylori infection confirmed by testing and have never been treated for it before
- You are at least 20 years old
- You are willing to take the study medications as prescribed for the full treatment period
- You are not pregnant, breastfeeding, or planning to become pregnant during the trial
- You do not have severe kidney disease, advanced liver disease, or active cancer
- You have not had your stomach surgically removed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination of medicines to get rid of H. pylori bacteria in people whose previous treatments have not worked. It aims to find a more effective way to clear the infection.
This trial tests a 14-day course of two medicines, vonoprazan and minocycline, to see how well they clear an H. pylori stomach infection. If you have H. pylori and haven't been treated for it before, this study may help you get rid of the infection.
This trial tests a new medication combined with standard antibiotics and bismuth to treat helicobacter pylori, a bacteria that can cause stomach ulcers. It aims to see if this combination is safe and effective in clearing the infection.
This study compares two treatments for an H. pylori stomach infection: taking two medicines (vonoprazan and amoxicillin) versus taking four medicines. Both treatments are given for 14 days.
This trial tests a 14-day bismuth-based combination therapy to get rid of H. pylori, a stomach bacteria that can cause ulcers and stomach discomfort. It is being studied in an area where some standard antibiotics may not work well, offering a possible alternative treatment.
This trial tests a new two-step antibiotic treatment for adults with chronic gastritis caused by H. pylori bacteria. If you have not been treated for H. pylori before and are between 18 and 70, you may be able to join.
Hear when a new HELICOBACTER PYLORI INFECTIONS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.